Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.
Frequently asked questions
What sector does Yungjin Pharm Co Ltd (003520) operate in?
Yungjin Pharm Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Yungjin Pharm Co Ltd (003520) current stock price?
As of the latest data, Yungjin Pharm Co Ltd stock price is ₩1,308, with a previous close of ₩1,277. Yungjin Pharm Co Ltd gained ₩31 in the last trading session, representing a 2.43% increase.
What is Yungjin Pharm Co Ltd (003520) current market capitalization?
Yungjin Pharm Co Ltd market cap is approximately 239.22 billion.
Does Yungjin Pharm Co Ltd (003520) pay dividends?
No. Yungjin Pharm Co Ltd does not pay a dividend.
What is Yungjin Pharm Co Ltd (003520) beta (volatility) score?
Yungjin Pharm Co Ltd has a beta of 0.715, indicating lower volatility than the overall market.